Related Experiment Video
Updated: Jul 7, 2026

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
Solid-state characterization of an NR2B selective N-methyl d-aspartate (NMDA) antagonist polymorphs
Takashi Kojima1, Morimichi Sato, Atsushi Omura
1Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan Inc., 5-2 Taketoyo, Aichi 470-2393, Japan. tak_kojimajpn@yahoo.co.jp
This study characterizes three polymorphic forms of compound A, an NR2B selective N-methyl D-aspartate (NMDA) antagonist. Forms II and III exhibit an enantiotropic relationship, with distinct crystal structures compared to form I.
Area of Science:
- Pharmaceutical Chemistry
- Solid-State Chemistry
- Crystallography
Background:
- Compound A, a selective NR2B antagonist for N-methyl D-aspartate (NMDA) receptors, exists in multiple crystalline forms.
- Polymorphism significantly impacts drug properties, including solubility, stability, and bioavailability.
Purpose of the Study:
- To prepare and characterize the known polymorphic forms (I and II) of compound A.
- To identify and investigate potential new polymorphic forms and their relationships.
- To elucidate the crystallographic differences between the identified forms.
Main Methods:
- Single crystal X-ray diffractometry for structural determination.
- Differential scanning calorimetry (DSC) for thermal analysis.
- Variable temperature powder X-ray diffractometry (VT-PXRD) for phase transitions and temperature-dependent behavior.
Main Results:
- Two polymorphs (forms I and II) were successfully prepared and characterized.
- DSC and VT-PXRD indicated the existence of at least three polymorphic forms (I, II, and a new form III).
- Forms II and III demonstrated an enantiotropic relationship, with distinct crystallographic parameters and molecular arrangements compared to form I.
Conclusions:
- Compound A exhibits complex polymorphism with at least three distinct crystalline forms.
- The enantiotropic relationship between forms II and III provides crucial insights into solid-state behavior.
- Understanding these polymorphic forms is essential for optimizing the development and formulation of compound A.
Related Concept Videos
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Crystal Field Theory - Tetrahedral and Square Planar Complexes
Crystal field theory (CFT) is applicable to molecules in geometries other than octahedral. In octahedral complexes, the lobes of the dx2−y2 and dz2 orbitals point directly at the ligands. For tetrahedral complexes, the d orbitals remain in place, but with only four ligands located between the axes. None of the orbitals points directly at the tetrahedral ligands. However, the dx2−y2 and dz2 orbitals (along the Cartesian axes) overlap with the ligands less than the dxy,...
Ionic Crystal Structures
Most monatomic ions behave as charged spheres, and their attraction for ions of opposite charge is the same in every direction. Consequently, stable structures for ionic compounds result (1) when ions of one charge are surrounded by as many ions as possible of the opposite...

